|
- Rheumatoid arthritis - Symptoms and causes - Mayo Clinic
Rheumatoid arthritis is an ongoing, called chronic, condition that causes pain, swelling and irritation, called inflammation, in the joints
- Rheumatoid arthritis - Diagnosis and treatment - Mayo Clinic
Treatment There is no cure for rheumatoid arthritis Joint damage can happen quickly without treatment But clinical studies show that easing of symptoms, called remission, is more likely with early treatment with medicines called disease-modifying antirheumatic drugs (DMARDs)
- Rheumatoid Arthritis: Diagnosis, Treatment, and Steps to Take
Doctors diagnose RA by: Taking a medical history Performing a physical exam Ordering laboratory tests Ordering imaging studies, such as x-rays or ultrasound It can be difficult to diagnose rheumatoid arthritis when it is in the early stages because: The disease develops over time, and only a few symptoms may be present in the early stages
- Osteoarthritis vs. rheumatoid arthritis - Mayo Clinic
Osteoarthritis, the most common form of arthritis, involves the wearing away of the cartilage that caps the bones in your joints Rheumatoid arthritis is a disease in which the immune system attacks the joints, beginning with the lining of joints There is a problem with information submitted for
- Rheumatoid factor - Mayo Clinic
Rheumatoid factor — Overview covers definition, risks, results of rheumatoid factor blood test
- Rheumatoid Arthritis: Research Resources - National Institute of . . .
Over the last several decades, research has greatly increased our understanding of the immune system, genetics, and biology This research is now showing results in several areas important to rheumatoid arthritis Scientists are thinking about RA in exciting ways that were not possible years ago Genetics
- Study Identifies Subtypes of Inflammation in People with Rheumatoid . . .
Rheumatoid arthritis (RA) is an autoimmune disease that causes joint inflammation, pain, and stiffness There are several treatment options to control inflammation, but response to therapy varies and some people with RA never reach remission, suggesting there may be different drivers of inflammation
- The Role of NIAMS in the Accelerating Medicines Partnership® (AMP®)
The AMP RA SLE Program brings together the NIH and medical community to address rheumatoid arthritis and lupus with diagnostic and drug advancements This public-private partnership seeks to develop new ways of identifying and validating promising biological targets for diagnostics and drug development
|
|
|